The results showed that the activity of the mutant STUB1 promoter was significantly lower than that of the wild type (Fig. 6G, H), indicating that NFAT can directly increase STUB1 promoter activity in CRTAC1-overexpressed NSCLC cells under the action of cisplatin. The gene discussed is CRTAC1; the disease is non-small cell lung carcinoma.